Male Contraception.
Birth Control
Contraception
Male Contraception
Reproduction
Journal
The Yale journal of biology and medicine
ISSN: 1551-4056
Titre abrégé: Yale J Biol Med
Pays: United States
ID NLM: 0417414
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
entrez:
2
10
2020
pubmed:
3
10
2020
medline:
21
10
2021
Statut:
epublish
Résumé
Unintended pregnancy is a global public health problem. Despite a variety of female contraceptive options, male contraceptive options are limited to the condom and vasectomy. Condoms have high failure rates and surgical vasectomy is not reliably reversible. There is a global need and desire for novel male contraceptive methods. Hormonal methods have progressed the furthest in clinical development and androgen plus progestin formulations hold promise as a marketable, reversible male contraceptive over the next decade. Investigators have tested androgen plus progestin approaches using oral, transdermal, subdermal, and injectable drug formulations and demonstrated the short-term safety and reversibility of hormonal male contraception. The most commonly reported side effects associated with hormonal male contraception include weight gain, acne, slight suppression of serum high-density cholesterol, mood changes, and changes in libido. Efficacy trials of hormonal male contraceptives have demonstrated contraceptive efficacy rates greater than that of condoms. Although there has been less progression in the development of nonhormonal male contraceptives, potentially reversible vaso-occlusive methods are currently in clinical trials in some countries. Various studies have confirmed both men and women's desire for novel male contraceptives. Barriers to development include an absence of investment from pharmaceutical companies, concerns regarding side effects and spermatogenic rebound with hormonal methods, and lack of clear reversibility and proven effectiveness of nonhormonal methods. The ultimate availability of male contraceptives could have an important impact on decreasing global unintended pregnancy rates (currently 40% of all pregnancies) and will be a step towards reproductive justice and greater equity in family planning.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
603-613Subventions
Organisme : NIDDK NIH HHS
ID : T32 DK007247
Pays : United States
Informations de copyright
Copyright ©2020, Yale Journal of Biology and Medicine.
Références
J Androl. 2005 May-Jun;26(3):405-13
pubmed: 15867009
Int J Androl. 2010 Feb;33(1):e198-206
pubmed: 19811546
Toxicol Appl Pharmacol. 1961 Jan;3:1-11
pubmed: 13713106
J Clin Endocrinol Metab. 2012 Oct;97(10):3476-86
pubmed: 22791756
Int J Androl. 2000 Feb;23(1):36-42
pubmed: 10632760
J Clin Endocrinol Metab. 2008 May;93(5):1774-83
pubmed: 18303073
Andrology. 2013 Mar;1(2):308-17
pubmed: 23408752
Lancet. 2006 Apr 29;367(9520):1412-20
pubmed: 16650651
Hum Reprod. 2000 Mar;15(3):637-45
pubmed: 10686211
Basic Clin Androl. 2016 Mar 30;26:6
pubmed: 27030808
Basic Clin Androl. 2017 Feb 7;27:4
pubmed: 28191316
Contraception. 1993 Oct;48(4):367-75
pubmed: 8222664
J Clin Endocrinol Metab. 2003 Feb;88(2):562-8
pubmed: 12574181
Contraception. 2010 Nov;82(5):410-7
pubmed: 20933114
Lancet Glob Health. 2018 Apr;6(4):e380-e389
pubmed: 29519649
J Clin Endocrinol Metab. 2006 Nov;91(11):4374-80
pubmed: 16940442
Lancet. 1990 Oct 20;336(8721):955-9
pubmed: 1977002
J Clin Endocrinol Metab. 2019 Mar 1;104(3):629-638
pubmed: 30252057
J Exp Med. 1925 Nov 30;42(6):753-77
pubmed: 19869087
J Clin Endocrinol Metab. 2009 Jul;94(7):2313-20
pubmed: 19366848
J Androl. 2007 Sep-Oct;28(5):679-88
pubmed: 17460095
Contraception. 2005 Mar;71(3):214-26
pubmed: 15722073
J Clin Endocrinol Metab. 2016 Dec;101(12):4779-4788
pubmed: 27788052
Contraception. 2007 Mar;75(3):218-23
pubmed: 17303493
Basic Clin Androl. 2017 Apr 5;27:8
pubmed: 28417005
Contraception. 1985 Jul;32(1):109-18
pubmed: 4053602
J Androl. 2011 Mar-Apr;32(2):183-92
pubmed: 20798389
Fertil Steril. 2018 Dec;110(7):1277-1284
pubmed: 30424879
Contraception. 2011 Apr;83(4):310-5
pubmed: 21397087
J Clin Endocrinol Metab. 2008 Jul;93(7):2572-80
pubmed: 18413423
J Clin Endocrinol Metab. 2009 Jun;94(6):1910-5
pubmed: 19293262
Fam Plann Perspect. 1995 May-Jun;27(3):123-8
pubmed: 7672104
Andrology. 2019 Nov;7(6):878-887
pubmed: 30969032
Reprod Health Matters. 2010 Nov;18(36):90-101
pubmed: 21111353
IPPF Med Bull. 1997 Dec;31(6):1-5
pubmed: 12321669
Endocrinology. 2011 Jun;152(6):2492-502
pubmed: 21505053
Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93
pubmed: 16117815
Hum Reprod. 2000 Mar;15(3):646-9
pubmed: 10686212
Fam Plann Perspect. 1996 Sep-Oct;28(5):221-6
pubmed: 8886765
Contraception. 1997 Oct;56(4):245-50
pubmed: 9408706
Asian J Androl. 2011 Jul;13(4):579-84
pubmed: 21317912
Hum Reprod. 2005 Feb;20(2):549-56
pubmed: 15608042
J Clin Endocrinol Metab. 2003 Nov;88(11):5232-9
pubmed: 14602755
Asian J Androl. 2017 Jul-Aug;19(4):389-395
pubmed: 27586026
Differentiation. 2005 Apr;73(4):188-98
pubmed: 15901285
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31976519
JAMA Intern Med. 2015 Jul;175(7):1187-96
pubmed: 25962056
Endocrinology. 1992 Jun;130(6):3677-83
pubmed: 1597164
J Clin Endocrinol Metab. 2019 Feb 1;104(2):423-432
pubmed: 30252061
Nat Med. 2006 Nov;12(11):1323-8
pubmed: 17072312
PLoS One. 2018 Apr 19;13(4):e0195953
pubmed: 29672554
Hum Reprod. 2001 Dec;16(12):2570-7
pubmed: 11726576
Perspect Sex Reprod Health. 2017 Mar;49(1):7-16
pubmed: 28245088
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13692-7
pubmed: 14585929
Biol Reprod. 2001 May;64(5):1500-8
pubmed: 11319158
Fertil Steril. 1996 Apr;65(4):821-9
pubmed: 8654646
ACS Chem Biol. 2018 Mar 16;13(3):582-590
pubmed: 29240402
J Androl. 2011 Jan-Feb;32(1):111-9
pubmed: 20705791
Andrology. 2018 Jan;6(1):10-19
pubmed: 29194998
Indian J Med Res. 2019 Jul;150(1):81-86
pubmed: 31571633
Science. 2004 Nov 12;306(5699):1189-90
pubmed: 15539605
Contraception. 2019 Jun;99(6):350-356
pubmed: 30763581
J Clin Endocrinol Metab. 1993 Aug;77(2):427-32
pubmed: 8345047
Contraception. 1998 Feb;57(2):125-32
pubmed: 9589840
Andrology. 2017 Mar;5(2):278-285
pubmed: 27907978
Curr Obstet Gynecol Rep. 2016;5:38-47
pubmed: 26949570
J Clin Endocrinol Metab. 2003 Oct;88(10):4659-67
pubmed: 14557437
Contraception. 2014 Oct;90(4):407-12
pubmed: 24981149
Biol Reprod. 2009 Feb;80(2):279-85
pubmed: 18945989
Contraception. 2020 Jan;101(1):26-33
pubmed: 31655068
J Clin Endocrinol Metab. 2010 Aug;95(8):3806-13
pubmed: 20484472
Endocrinology. 2016 Apr;157(4):1601-12
pubmed: 26812157
Contraception. 2018 Jan;97(1):62-69
pubmed: 28887053
J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75
pubmed: 20525906
PLoS One. 2009 Aug 31;4(8):e6844
pubmed: 19718436
Hum Reprod. 2006 Aug;21(8):2033-40
pubmed: 16731547
Contraception. 1998 Aug;58(2):119-28
pubmed: 9773267
Expert Opin Pharmacother. 2014 Jun;15(9):1247-64
pubmed: 24758365
J Clin Endocrinol Metab. 1996 Feb;81(2):757-62
pubmed: 8636300